Waystar Holding Corp. WAY 深 滬
已收盤 04-02 16:00:00 美东时间
23.74
-0.030
-0.13%
華盛通- 最 高24.71
- 今 開23.77
- 成交量 159.54万股
- 最 低 23.435
- 昨 收 23.77
- 總市值 45.51亿
- 52周最高 42.55
- 市盈率 靜 39.14
- 換手率 0.83%
- 52周最低 21.13
- 委 比 -91.90%
- 總股本 1.92亿
- 歷史最高 48.11
- 量 比 0.67
- 振 幅 5.36%
- 歷史最低 20.26
- 每 手 1
- 風險率 5.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Morgan Stanley Initiates Coverage On Waystar Holding with Equal-Weight Rating, Announces Price Target of $28
Morgan Stanley analyst Craig Hettenbach initiates coverage on Waystar Holding (NASDAQ:WAY) with a Equal-Weight rating and announces Price Target of $28.
03-31 02:10
美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
Deutsche Bank Maintains Buy on Waystar Holding, Lowers Price Target to $37
Deutsche Bank analyst George Hill maintains Waystar Holding (NASDAQ:WAY) with a Buy and lowers the price target from $42 to $37.
03-13 02:02
Waystar Expands Google Cloud Partnership to Accelerate Agentic AI Revenue Cycle
Waystar Expands Google Cloud Partnership to Accelerate Agentic AI Revenue Cycle Waystar Holding Corp. has expanded its collaboration with Google Cloud to accelerate agentic AI capabilities in its healthcare revenue cycle platform. The partnership will deepen integration of Google Cloud’s Gemini mode
03-05 22:05
Waystar AI Delivers Industry-Leading Outcomes, Earns #1 Client Ranking
Black Book survey of more than 750 healthcare leaders demonstrates that Waystar leads the industry in client satisfaction with AI execution and outcomes LEHI, Utah, and LOUISVILLE, Ky., Feb....
02-20 22:00
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
美股大行评级 | 潜在涨幅1226.53%！RenovoRx获Ascendiant Capital升目标价至13美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从12.5美元升至13美元；Lake Street：维持Insight Molecular"买入"评级，目标价从8美元升至12美元
02-18 16:48
Waystar Holding Corp. Signals Confident, Profitable Growth
Waystar Holding Corp. (($WAY)) has held its Q4 earnings call. Read on for the m...
02-18 08:25
